中文 English

A digital simulation platform for mining intrinsic mechanisms
of actions (MOAs) of drugs

Establishing digital models reflecting etiologies and pathologies of human diseases as well as pharmacology and MOAs of drugs

Systematically delivering novel targets
and new MOAs of drugs

Boosting new drug pipelines for unmet clinical needs

Virtual clinical trials

※    Accurate assessment of drug targets
※    Precise simulation of drug efficacy
※    Precisely pinpoint applicable indications
※    Accurately predicting responders to therapies

Company dynamics

CAPR2022 | Phil Rivers Invited to Share New Practice of "AI+ Disease"

Company dynamics

CSDR and Relevant Units to Investigate "Computational Medicine"

  • 京ICP备17032047号© 2019 PHIL RIVERS TECHNOLOGY Co.,Ltd All rights reserved
  • support@philrivers.com
  • ※   Room 314, Office of CHINA SCIENCE DAILY, B3 South No.1 Road, Zhongguancun, Haidian District, Beijing, China
    ※   Industrialization Complex Building,Rm B603-B604,Shenzhen Virtual University,Shenzhen,China
support@philrivers.com
Room 314, Office of CHINA SCIENCE DAILY, B3 South No.1 Road, Zhongguancun, Haidian District, Beijing, China
Industrialization Complex Building,Rm B603-B604,Shenzhen Virtual University,Shenzhen,China
京ICP备17032047号 © 2019 PHIL RIVERS TECHNOLOGY Co.,Ltd All rights reserved

扫一扫关注公众号